

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.42489090 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.00505589 |
| 3 | vocalization behavior (GO:0071625) | 4.99646498 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.92578728 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.67285678 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.62532657 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.54470132 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.42915483 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.35554049 |
| 10 | glutamate secretion (GO:0014047) | 4.34165057 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.30668064 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.27661789 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.19482759 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.10526285 |
| 15 | regulation of ARF protein signal transduction (GO:0032012) | 4.06894084 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93156972 |
| 17 | proline transport (GO:0015824) | 3.91033327 |
| 18 | postsynaptic membrane organization (GO:0001941) | 3.90944648 |
| 19 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.90244871 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.89306050 |
| 21 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.85303723 |
| 22 | exploration behavior (GO:0035640) | 3.85233883 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.81884562 |
| 24 | protein localization to synapse (GO:0035418) | 3.75893952 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.68404941 |
| 26 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.68362976 |
| 27 | positive regulation of synapse maturation (GO:0090129) | 3.68125774 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.67227510 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.64273757 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.55815400 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.49518742 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.40504050 |
| 33 | mannose metabolic process (GO:0006013) | 3.39616954 |
| 34 | long-term synaptic potentiation (GO:0060291) | 3.37789483 |
| 35 | response to pheromone (GO:0019236) | 3.33979774 |
| 36 | neuron recognition (GO:0008038) | 3.33490071 |
| 37 | negative regulation of norepinephrine secretion (GO:0010700) | 3.33343837 |
| 38 | neuronal action potential propagation (GO:0019227) | 3.33075591 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.30145647 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.29226881 |
| 41 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.28033818 |
| 42 | axonal fasciculation (GO:0007413) | 3.27042555 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 3.26104766 |
| 44 | presynaptic membrane assembly (GO:0097105) | 3.20068061 |
| 45 | neurotransmitter transport (GO:0006836) | 3.19432870 |
| 46 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19304813 |
| 47 | regulation of ARF GTPase activity (GO:0032312) | 3.18118774 |
| 48 | layer formation in cerebral cortex (GO:0021819) | 3.17521620 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17356384 |
| 50 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.16485506 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.15721475 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.14979752 |
| 53 | protein localization to endosome (GO:0036010) | 3.11289825 |
| 54 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.06652257 |
| 55 | cellular response to catecholamine stimulus (GO:0071870) | 3.06295849 |
| 56 | cellular response to monoamine stimulus (GO:0071868) | 3.06295849 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.05530336 |
| 58 | behavioral defense response (GO:0002209) | 3.03059921 |
| 59 | behavioral fear response (GO:0001662) | 3.03059921 |
| 60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.00794022 |
| 61 | negative regulation of microtubule polymerization (GO:0031115) | 2.98297898 |
| 62 | regulation of synaptic plasticity (GO:0048167) | 2.98161136 |
| 63 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97993383 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.97714107 |
| 65 | cerebellar granule cell differentiation (GO:0021707) | 2.97639852 |
| 66 | positive regulation of synapse assembly (GO:0051965) | 2.96685102 |
| 67 | neuronal ion channel clustering (GO:0045161) | 2.95010097 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94840165 |
| 69 | negative regulation of cell killing (GO:0031342) | 2.94840165 |
| 70 | negative regulation of cell size (GO:0045792) | 2.94216222 |
| 71 | innervation (GO:0060384) | 2.93399329 |
| 72 | synaptic vesicle endocytosis (GO:0048488) | 2.92291674 |
| 73 | gamma-aminobutyric acid transport (GO:0015812) | 2.91980702 |
| 74 | cell migration in hindbrain (GO:0021535) | 2.91380335 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 2.90896531 |
| 76 | fear response (GO:0042596) | 2.90774023 |
| 77 | negative regulation of catecholamine secretion (GO:0033604) | 2.90431029 |
| 78 | cell communication by electrical coupling (GO:0010644) | 2.90044656 |
| 79 | regulation of neurotransmitter levels (GO:0001505) | 2.86414337 |
| 80 | cerebellar Purkinje cell layer development (GO:0021680) | 2.86067985 |
| 81 | dendritic spine morphogenesis (GO:0060997) | 2.84673003 |
| 82 | response to histamine (GO:0034776) | 2.84348821 |
| 83 | protein retention in ER lumen (GO:0006621) | 2.84297934 |
| 84 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.83018238 |
| 85 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81505060 |
| 86 | long-term memory (GO:0007616) | 2.80357035 |
| 87 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.79497158 |
| 88 | positive regulation of fibroblast migration (GO:0010763) | 2.77356266 |
| 89 | regulation of defense response to virus by virus (GO:0050690) | 2.77066867 |
| 90 | presynaptic membrane organization (GO:0097090) | 2.74871030 |
| 91 | female mating behavior (GO:0060180) | 2.74495942 |
| 92 | membrane hyperpolarization (GO:0060081) | 2.73113589 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72744136 |
| 94 | Rac protein signal transduction (GO:0016601) | 2.71825074 |
| 95 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.71510282 |
| 96 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.70083895 |
| 97 | mitochondrion transport along microtubule (GO:0047497) | 2.70083895 |
| 98 | regulation of glutamate secretion (GO:0014048) | 2.69457552 |
| 99 | regulation of synapse organization (GO:0050807) | 2.68994175 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.68600474 |
| 101 | dendrite morphogenesis (GO:0048813) | 2.68475196 |
| 102 | regulation of female receptivity (GO:0045924) | 2.67707960 |
| 103 | cell-cell junction maintenance (GO:0045217) | 2.67191455 |
| 104 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.67103018 |
| 105 | transferrin transport (GO:0033572) | 2.66133496 |
| 106 | axon extension (GO:0048675) | 2.65877076 |
| 107 | COPI coating of Golgi vesicle (GO:0048205) | 2.64560912 |
| 108 | Golgi transport vesicle coating (GO:0048200) | 2.64560912 |
| 109 | membrane depolarization (GO:0051899) | 2.64194775 |
| 110 | regulation of neurotransmitter transport (GO:0051588) | 2.63941860 |
| 111 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.62443995 |
| 112 | establishment of nucleus localization (GO:0040023) | 2.62349541 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.61622017 |
| 114 | positive regulation of synaptic transmission (GO:0050806) | 2.60597646 |
| 115 | activation of protein kinase A activity (GO:0034199) | 2.60261594 |
| 116 | synaptic vesicle transport (GO:0048489) | 2.58827641 |
| 117 | establishment of synaptic vesicle localization (GO:0097480) | 2.58827641 |
| 118 | synapse organization (GO:0050808) | 2.58469931 |
| 119 | cochlea development (GO:0090102) | 2.58079683 |
| 120 | behavioral response to cocaine (GO:0048148) | 2.55584821 |
| 121 | regulation of vesicle fusion (GO:0031338) | 2.55293868 |
| 122 | auditory behavior (GO:0031223) | 2.55119727 |
| 123 | positive regulation of protein dephosphorylation (GO:0035307) | 2.54896324 |
| 124 | learning (GO:0007612) | 2.54818890 |
| 125 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.54683701 |
| 126 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.54683701 |
| 127 | sodium ion export (GO:0071436) | 2.52149018 |
| 128 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.51599435 |
| 129 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.51515112 |
| 130 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.50907968 |
| 131 | amino acid import (GO:0043090) | 2.48380138 |
| 132 | response to monoamine (GO:0071867) | 2.45373713 |
| 133 | response to catecholamine (GO:0071869) | 2.45373713 |
| 134 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.36122023 |
| 135 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35858081 |
| 136 | neuron projection extension (GO:1990138) | 2.35529762 |
| 137 | protein targeting to plasma membrane (GO:0072661) | 2.34702261 |
| 138 | dopamine receptor signaling pathway (GO:0007212) | 2.33254424 |
| 139 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.30826775 |
| 140 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.29828651 |
| 141 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.29653164 |
| 142 | semaphorin-plexin signaling pathway (GO:0071526) | 2.29557210 |
| 143 | chondroitin sulfate catabolic process (GO:0030207) | 2.29420525 |
| 144 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.27386737 |
| 145 | L-amino acid import (GO:0043092) | 2.27233222 |
| 146 | dendritic spine organization (GO:0097061) | 2.26391843 |
| 147 | response to parathyroid hormone (GO:0071107) | 2.25897366 |
| 148 | cellular potassium ion homeostasis (GO:0030007) | 2.25779113 |
| 149 | activation of JUN kinase activity (GO:0007257) | 2.25772585 |
| 150 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.25125931 |
| 151 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.21732880 |
| 152 | cell junction maintenance (GO:0034331) | 2.20415753 |
| 153 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.19427326 |
| 154 | respiratory system process (GO:0003016) | 2.17358098 |
| 155 | histone H3-K9 demethylation (GO:0033169) | 2.16824087 |
| 156 | signal complex assembly (GO:0007172) | 2.16254539 |
| 157 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 2.16129475 |
| 158 | positive regulation by symbiont of host defense response (GO:0052509) | 2.14740965 |
| 159 | modulation by symbiont of host defense response (GO:0052031) | 2.14740965 |
| 160 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.14740965 |
| 161 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.14740965 |
| 162 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.14740965 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.14740965 |
| 164 | negative regulation of necrotic cell death (GO:0060547) | 2.14482874 |
| 165 | stress fiber assembly (GO:0043149) | 2.14188148 |
| 166 | neuromuscular process controlling balance (GO:0050885) | 2.12774740 |
| 167 | negative regulation of catenin import into nucleus (GO:0035414) | 2.12288379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.76472989 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75649838 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.72175522 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.55729892 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.01085519 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99727831 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.86979182 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.86391321 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85021373 |
| 10 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.76976917 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73715976 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59087932 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59087932 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56704846 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54528760 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.54383815 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49492712 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.48712623 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46257636 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44091749 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43929986 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.41993770 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 2.36641972 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.36611559 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.36611182 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.25584759 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18910763 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17302908 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.14874232 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10988743 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06278691 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.98793283 |
| 33 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95409762 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88727061 |
| 35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.88629038 |
| 36 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.84325058 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.84283314 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81806933 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80909030 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.80799605 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79599006 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76156182 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72731651 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.71959485 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.70998590 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70854357 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70732348 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69250484 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.63827513 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61973891 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61003531 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58770091 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58509656 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58402862 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.58250515 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.57854718 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57679873 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56689116 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55885186 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.54279476 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54107899 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54039248 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.53966686 |
| 64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51198221 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50222644 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49156831 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47435386 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45461417 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45433318 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.45212347 |
| 71 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.40531676 |
| 72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.39878690 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39185432 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37770741 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35361322 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34933814 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34869823 |
| 78 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33196370 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32817691 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32148280 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.31993449 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31240182 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30657476 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30286223 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29738357 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.29734889 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28935200 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28808502 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.27000484 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26653093 |
| 91 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.25264751 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24934198 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23531370 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23524307 |
| 95 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.22138476 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21440483 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20902125 |
| 98 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18882016 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18748166 |
| 100 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18723671 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 1.18130992 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17401887 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16402052 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16240573 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15984435 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15500257 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15086204 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14137217 |
| 109 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.13944167 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13924632 |
| 111 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.13071077 |
| 112 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.13067636 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 1.12285054 |
| 114 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12007153 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11819434 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11141857 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09314428 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08799473 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08253262 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08253169 |
| 121 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08070368 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07707537 |
| 123 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07640204 |
| 124 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06771479 |
| 125 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06647159 |
| 126 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.05639447 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05338583 |
| 128 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05062387 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03448765 |
| 130 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.03209876 |
| 131 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02976310 |
| 132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02365306 |
| 133 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00702356 |
| 134 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00439312 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00399522 |
| 136 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00072706 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95810360 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95768681 |
| 139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95591188 |
| 140 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95482808 |
| 141 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94644921 |
| 142 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94559670 |
| 143 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94558322 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94274305 |
| 145 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93289371 |
| 146 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93286165 |
| 147 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91879599 |
| 148 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90713270 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90702767 |
| 150 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89445956 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88038326 |
| 152 | * JUN_21703547_ChIP-Seq_K562_Human | 0.87593848 |
| 153 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.87290033 |
| 154 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87195951 |
| 155 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87152519 |
| 156 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.86641093 |
| 157 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86210661 |
| 158 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.85951752 |
| 159 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.85891920 |
| 160 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83188644 |
| 161 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.82205402 |
| 162 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81153782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.10746736 |
| 2 | MP0003880_abnormal_central_pattern | 3.63881006 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.37054690 |
| 4 | MP0003122_maternal_imprinting | 3.31464677 |
| 5 | MP0008260_abnormal_autophagy | 3.26696131 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.22449554 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.15943244 |
| 8 | MP0004270_analgesia | 2.90121285 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.81056850 |
| 10 | MP0009745_abnormal_behavioral_response | 2.53152915 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.45202365 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.38401333 |
| 13 | MP0002064_seizures | 2.31609935 |
| 14 | MP0001958_emphysema | 2.24984103 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.17160920 |
| 16 | MP0009046_muscle_twitch | 2.15868599 |
| 17 | MP0004130_abnormal_muscle_cell | 2.10015246 |
| 18 | MP0006276_abnormal_autonomic_nervous | 2.04490627 |
| 19 | MP0001188_hyperpigmentation | 2.03841454 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 2.03637845 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 1.99615518 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.92401654 |
| 23 | MP0002736_abnormal_nociception_after | 1.86955272 |
| 24 | MP0002272_abnormal_nervous_system | 1.83826580 |
| 25 | MP0003123_paternal_imprinting | 1.83161510 |
| 26 | MP0002249_abnormal_larynx_morphology | 1.82916481 |
| 27 | MP0001348_abnormal_lacrimal_gland | 1.82763421 |
| 28 | MP0000604_amyloidosis | 1.80071481 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.74794438 |
| 30 | MP0005248_abnormal_Harderian_gland | 1.73161856 |
| 31 | MP0005171_absent_coat_pigmentation | 1.73066964 |
| 32 | MP0002822_catalepsy | 1.72670926 |
| 33 | MP0002184_abnormal_innervation | 1.72004834 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.71714274 |
| 35 | MP0003121_genomic_imprinting | 1.70360848 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.70190085 |
| 37 | MP0003283_abnormal_digestive_organ | 1.69063030 |
| 38 | MP0000778_abnormal_nervous_system | 1.67992999 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.66840243 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.64774380 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.64656976 |
| 42 | MP0003279_aneurysm | 1.63654722 |
| 43 | MP0004858_abnormal_nervous_system | 1.61769763 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.59805841 |
| 45 | MP0001486_abnormal_startle_reflex | 1.56375597 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.56202804 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.53921580 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.51245238 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.50810072 |
| 50 | MP0003787_abnormal_imprinting | 1.50404545 |
| 51 | MP0001970_abnormal_pain_threshold | 1.49103383 |
| 52 | MP0003690_abnormal_glial_cell | 1.46557329 |
| 53 | MP0004811_abnormal_neuron_physiology | 1.42906599 |
| 54 | MP0003634_abnormal_glial_cell | 1.41559793 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.41296427 |
| 56 | MP0005423_abnormal_somatic_nervous | 1.40604582 |
| 57 | MP0001529_abnormal_vocalization | 1.40239003 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.37505506 |
| 59 | MP0009278_abnormal_bone_marrow | 1.37501928 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.36668978 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.32439279 |
| 62 | MP0000747_muscle_weakness | 1.31413280 |
| 63 | MP0000955_abnormal_spinal_cord | 1.31337565 |
| 64 | MP0004233_abnormal_muscle_weight | 1.30740056 |
| 65 | MP0003436_decreased_susceptibility_to | 1.30421891 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.30374289 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.29340429 |
| 68 | MP0004924_abnormal_behavior | 1.29340429 |
| 69 | MP0001849_ear_inflammation | 1.27284757 |
| 70 | MP0003303_peritoneal_inflammation | 1.27221905 |
| 71 | MP0003385_abnormal_body_wall | 1.25558350 |
| 72 | MP0005451_abnormal_body_composition | 1.25111450 |
| 73 | MP0003091_abnormal_cell_migration | 1.21684062 |
| 74 | MP0000759_abnormal_skeletal_muscle | 1.21260286 |
| 75 | MP0000003_abnormal_adipose_tissue | 1.18462609 |
| 76 | MP0009840_abnormal_foam_cell | 1.18145584 |
| 77 | MP0003879_abnormal_hair_cell | 1.18027768 |
| 78 | MP0005503_abnormal_tendon_morphology | 1.15663755 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.14176052 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 1.13116307 |
| 81 | MP0008569_lethality_at_weaning | 1.12976415 |
| 82 | MP0000751_myopathy | 1.10536643 |
| 83 | MP0002876_abnormal_thyroid_physiology | 1.09095050 |
| 84 | MP0000534_abnormal_ureter_morphology | 1.08783426 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.06342805 |
| 86 | MP0002152_abnormal_brain_morphology | 1.05943636 |
| 87 | MP0004510_myositis | 1.05755357 |
| 88 | MP0000920_abnormal_myelination | 1.05090855 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 1.04603412 |
| 90 | MP0005375_adipose_tissue_phenotype | 1.02036723 |
| 91 | MP0001299_abnormal_eye_distance/ | 1.01123463 |
| 92 | MP0002971_abnormal_brown_adipose | 0.99189840 |
| 93 | MP0000733_abnormal_muscle_development | 0.96288486 |
| 94 | MP0003119_abnormal_digestive_system | 0.95960257 |
| 95 | MP0001984_abnormal_olfaction | 0.94001835 |
| 96 | MP0008874_decreased_physiological_sensi | 0.93128859 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.90352125 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.89416454 |
| 99 | MP0004085_abnormal_heartbeat | 0.88930576 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.88908136 |
| 101 | MP0003632_abnormal_nervous_system | 0.88267799 |
| 102 | MP0001542_abnormal_bone_strength | 0.87793475 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.87009970 |
| 104 | MP0003942_abnormal_urinary_system | 0.86893435 |
| 105 | MP0001905_abnormal_dopamine_level | 0.86201706 |
| 106 | MP0004272_abnormal_basement_membrane | 0.85918812 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.85526758 |
| 108 | MP0004142_abnormal_muscle_tone | 0.83542949 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.83108066 |
| 110 | MP0000049_abnormal_middle_ear | 0.81945635 |
| 111 | MP0003045_fibrosis | 0.78502197 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.76457895 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.75575952 |
| 114 | MP0003878_abnormal_ear_physiology | 0.75575952 |
| 115 | MP0004883_abnormal_blood_vessel | 0.75367348 |
| 116 | MP0009250_abnormal_appendicular_skeleto | 0.74043510 |
| 117 | MP0001986_abnormal_taste_sensitivity | 0.73610591 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.73470703 |
| 119 | MP0001177_atelectasis | 0.72768648 |
| 120 | MP0000749_muscle_degeneration | 0.72280573 |
| 121 | MP0003861_abnormal_nervous_system | 0.72241233 |
| 122 | MP0004885_abnormal_endolymph | 0.70768411 |
| 123 | MP0001270_distended_abdomen | 0.70482503 |
| 124 | MP0005409_darkened_coat_color | 0.70161763 |
| 125 | MP0004087_abnormal_muscle_fiber | 0.69142606 |
| 126 | MP0000026_abnormal_inner_ear | 0.69040913 |
| 127 | MP0000681_abnormal_thyroid_gland | 0.68342402 |
| 128 | MP0002751_abnormal_autonomic_nervous | 0.68120479 |
| 129 | MP0003115_abnormal_respiratory_system | 0.68057131 |
| 130 | MP0002419_abnormal_innate_immunity | 0.67669940 |
| 131 | MP0003948_abnormal_gas_homeostasis | 0.67490591 |
| 132 | MP0003329_amyloid_beta_deposits | 0.67440466 |
| 133 | MP0002970_abnormal_white_adipose | 0.67301711 |
| 134 | MP0002269_muscular_atrophy | 0.67198045 |
| 135 | MP0002638_abnormal_pupillary_reflex | 0.65634350 |
| 136 | MP0001664_abnormal_digestion | 0.64287350 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.63963891 |
| 138 | MP0003755_abnormal_palate_morphology | 0.63615369 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.63328519 |
| 140 | MP0003633_abnormal_nervous_system | 0.61810586 |
| 141 | MP0001943_abnormal_respiration | 0.61545018 |
| 142 | MP0006138_congestive_heart_failure | 0.61401832 |
| 143 | MP0003631_nervous_system_phenotype | 0.60660459 |
| 144 | MP0005535_abnormal_body_temperature | 0.60390213 |
| 145 | MP0002108_abnormal_muscle_morphology | 0.57410968 |
| 146 | MP0002081_perinatal_lethality | 0.56518156 |
| 147 | MP0008438_abnormal_cutaneous_collagen | 0.56484879 |
| 148 | MP0003137_abnormal_impulse_conducting | 0.56412978 |
| 149 | MP0003172_abnormal_lysosome_physiology | 0.55988971 |
| 150 | MP0005394_taste/olfaction_phenotype | 0.55985097 |
| 151 | MP0005499_abnormal_olfactory_system | 0.55985097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.05495072 |
| 2 | Atonic seizures (HP:0010819) | 4.07866639 |
| 3 | Epileptic encephalopathy (HP:0200134) | 4.07111070 |
| 4 | Focal seizures (HP:0007359) | 3.78159784 |
| 5 | Visual hallucinations (HP:0002367) | 3.61229887 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.54633966 |
| 7 | Myokymia (HP:0002411) | 3.45451795 |
| 8 | Amblyopia (HP:0000646) | 3.28414988 |
| 9 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.08281384 |
| 10 | Febrile seizures (HP:0002373) | 2.91914276 |
| 11 | Absence seizures (HP:0002121) | 2.89152814 |
| 12 | Broad face (HP:0000283) | 2.74428528 |
| 13 | Hyperventilation (HP:0002883) | 2.74047577 |
| 14 | Cervical subluxation (HP:0003308) | 2.68087399 |
| 15 | Papilledema (HP:0001085) | 2.67113236 |
| 16 | Increased variability in muscle fiber diameter (HP:0003557) | 2.65965229 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 2.65108868 |
| 18 | Epileptiform EEG discharges (HP:0011182) | 2.63946964 |
| 19 | Protrusio acetabuli (HP:0003179) | 2.60906498 |
| 20 | Hyperacusis (HP:0010780) | 2.60616523 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 2.58988603 |
| 22 | Neuronal loss in central nervous system (HP:0002529) | 2.54698562 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.54432959 |
| 24 | Dialeptic seizures (HP:0011146) | 2.53944025 |
| 25 | Poor eye contact (HP:0000817) | 2.52877440 |
| 26 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51294421 |
| 27 | Peripheral hypomyelination (HP:0007182) | 2.50833015 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.49156839 |
| 29 | Distal upper limb amyotrophy (HP:0007149) | 2.46954013 |
| 30 | Upper limb amyotrophy (HP:0009129) | 2.46954013 |
| 31 | Hypsarrhythmia (HP:0002521) | 2.42323521 |
| 32 | Increased connective tissue (HP:0009025) | 2.40267618 |
| 33 | Narrow nasal bridge (HP:0000446) | 2.36277960 |
| 34 | Hand muscle atrophy (HP:0009130) | 2.34875465 |
| 35 | Stridor (HP:0010307) | 2.33695047 |
| 36 | Vertebral compression fractures (HP:0002953) | 2.33679479 |
| 37 | Impaired smooth pursuit (HP:0007772) | 2.33190681 |
| 38 | Premature rupture of membranes (HP:0001788) | 2.29698725 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.29130357 |
| 40 | Limb dystonia (HP:0002451) | 2.28246757 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.28177215 |
| 42 | Sleep apnea (HP:0010535) | 2.27657337 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.26781365 |
| 44 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24566498 |
| 45 | J-shaped sella turcica (HP:0002680) | 2.23445015 |
| 46 | Mitral regurgitation (HP:0001653) | 2.23269945 |
| 47 | Depression (HP:0000716) | 2.22158293 |
| 48 | Hyperthyroidism (HP:0000836) | 2.21840405 |
| 49 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21753752 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19941025 |
| 51 | Failure to thrive in infancy (HP:0001531) | 2.19428715 |
| 52 | Excessive salivation (HP:0003781) | 2.19161565 |
| 53 | Drooling (HP:0002307) | 2.19161565 |
| 54 | Atelectasis (HP:0100750) | 2.16600714 |
| 55 | Spastic gait (HP:0002064) | 2.14222611 |
| 56 | Hypoventilation (HP:0002791) | 2.13704323 |
| 57 | Severe visual impairment (HP:0001141) | 2.12019904 |
| 58 | Protruding tongue (HP:0010808) | 2.11988645 |
| 59 | Truncal ataxia (HP:0002078) | 2.09983242 |
| 60 | Abnormal social behavior (HP:0012433) | 2.08243766 |
| 61 | Impaired social interactions (HP:0000735) | 2.08243766 |
| 62 | Type 1 muscle fiber predominance (HP:0003803) | 2.07801959 |
| 63 | Spinal rigidity (HP:0003306) | 2.07252453 |
| 64 | Blue irides (HP:0000635) | 2.05567952 |
| 65 | Disproportionate tall stature (HP:0001519) | 2.05153216 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.04045774 |
| 67 | Biconcave vertebral bodies (HP:0004586) | 2.02497276 |
| 68 | Broad-based gait (HP:0002136) | 2.02480853 |
| 69 | Polyphagia (HP:0002591) | 2.02146459 |
| 70 | Bowel incontinence (HP:0002607) | 2.01065883 |
| 71 | Ankle clonus (HP:0011448) | 2.01022693 |
| 72 | Flared iliac wings (HP:0002869) | 2.00730948 |
| 73 | Hemiparesis (HP:0001269) | 1.98925410 |
| 74 | Torticollis (HP:0000473) | 1.98147279 |
| 75 | Abnormal eating behavior (HP:0100738) | 1.96873120 |
| 76 | Pheochromocytoma (HP:0002666) | 1.96362012 |
| 77 | Diplopia (HP:0000651) | 1.95046915 |
| 78 | Abnormality of binocular vision (HP:0011514) | 1.95046915 |
| 79 | Turricephaly (HP:0000262) | 1.93273768 |
| 80 | Bowel diverticulosis (HP:0005222) | 1.93137456 |
| 81 | Deep palmar crease (HP:0006191) | 1.90180585 |
| 82 | Hypercortisolism (HP:0001578) | 1.90021177 |
| 83 | Dysostosis multiplex (HP:0000943) | 1.89590138 |
| 84 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89285385 |
| 85 | Heterochromia iridis (HP:0001100) | 1.89243285 |
| 86 | Peritonitis (HP:0002586) | 1.88624394 |
| 87 | Abnormality of the calcaneus (HP:0008364) | 1.88143633 |
| 88 | Long palpebral fissure (HP:0000637) | 1.87325872 |
| 89 | Intellectual disability, profound (HP:0002187) | 1.87257536 |
| 90 | Bradykinesia (HP:0002067) | 1.86983456 |
| 91 | Difficulty running (HP:0009046) | 1.86772481 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86654539 |
| 93 | Exercise-induced myalgia (HP:0003738) | 1.86584312 |
| 94 | Difficulty climbing stairs (HP:0003551) | 1.86507817 |
| 95 | Bladder diverticulum (HP:0000015) | 1.86094160 |
| 96 | Spinal canal stenosis (HP:0003416) | 1.85678020 |
| 97 | Dilatation of the ascending aorta (HP:0005111) | 1.85610595 |
| 98 | Focal dystonia (HP:0004373) | 1.85561933 |
| 99 | Apathy (HP:0000741) | 1.85560127 |
| 100 | Gait imbalance (HP:0002141) | 1.83959130 |
| 101 | Achilles tendon contracture (HP:0001771) | 1.82155224 |
| 102 | Anxiety (HP:0000739) | 1.82140002 |
| 103 | Abnormal large intestine physiology (HP:0012700) | 1.82013444 |
| 104 | Rapidly progressive (HP:0003678) | 1.81656180 |
| 105 | Diminished motivation (HP:0000745) | 1.81432146 |
| 106 | Annular pancreas (HP:0001734) | 1.79579161 |
| 107 | Abnormality of the lower motor neuron (HP:0002366) | 1.78863175 |
| 108 | Gaze-evoked nystagmus (HP:0000640) | 1.78744213 |
| 109 | Slow saccadic eye movements (HP:0000514) | 1.77854833 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 1.77220402 |
| 111 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.77208646 |
| 112 | Hypoplasia of the brainstem (HP:0002365) | 1.77208646 |
| 113 | Dysdiadochokinesis (HP:0002075) | 1.76874193 |
| 114 | Abnormality of pain sensation (HP:0010832) | 1.76450988 |
| 115 | Impaired pain sensation (HP:0007328) | 1.76450988 |
| 116 | Neoplasm of the adrenal cortex (HP:0100641) | 1.75463811 |
| 117 | Vascular tortuosity (HP:0004948) | 1.74266602 |
| 118 | Broad distal phalanx of finger (HP:0009836) | 1.74126063 |
| 119 | Shoulder girdle muscle weakness (HP:0003547) | 1.74077353 |
| 120 | Hammertoe (HP:0001765) | 1.73897648 |
| 121 | Akinesia (HP:0002304) | 1.73864338 |
| 122 | Thin bony cortex (HP:0002753) | 1.73723514 |
| 123 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73591370 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73591370 |
| 125 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73591370 |
| 126 | Shallow orbits (HP:0000586) | 1.72403535 |
| 127 | Foot dorsiflexor weakness (HP:0009027) | 1.72327573 |
| 128 | Arterial tortuosity (HP:0005116) | 1.71983706 |
| 129 | Aortic aneurysm (HP:0004942) | 1.71871013 |
| 130 | Calcaneovalgus deformity (HP:0001848) | 1.70995657 |
| 131 | Hepatoblastoma (HP:0002884) | 1.70186937 |
| 132 | Craniofacial dystonia (HP:0012179) | 1.69717222 |
| 133 | Aneurysm (HP:0002617) | 1.69554878 |
| 134 | Truncus arteriosus (HP:0001660) | 1.69105560 |
| 135 | Supernumerary nipples (HP:0002558) | 1.69032851 |
| 136 | Scapular winging (HP:0003691) | 1.68927647 |
| 137 | Urinary urgency (HP:0000012) | 1.68477917 |
| 138 | Insomnia (HP:0100785) | 1.68433721 |
| 139 | Lower limb muscle weakness (HP:0007340) | 1.67936006 |
| 140 | Cellulitis (HP:0100658) | 1.67882389 |
| 141 | Orthostatic hypotension (HP:0001278) | 1.67850927 |
| 142 | Distal lower limb amyotrophy (HP:0008944) | 1.67270829 |
| 143 | Gingivitis (HP:0000230) | 1.67154677 |
| 144 | Postural instability (HP:0002172) | 1.66524043 |
| 145 | Renal duplication (HP:0000075) | 1.66362390 |
| 146 | Absent speech (HP:0001344) | 1.66299772 |
| 147 | Macroglossia (HP:0000158) | 1.65801743 |
| 148 | Scanning speech (HP:0002168) | 1.64665217 |
| 149 | Dislocated radial head (HP:0003083) | 1.64545073 |
| 150 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.64371365 |
| 151 | Genetic anticipation (HP:0003743) | 1.64175340 |
| 152 | Resting tremor (HP:0002322) | 1.62290668 |
| 153 | Ulnar bowing (HP:0003031) | 1.62197094 |
| 154 | Long toe (HP:0010511) | 1.62162464 |
| 155 | Shawl scrotum (HP:0000049) | 1.61929234 |
| 156 | Slender build (HP:0001533) | 1.61471026 |
| 157 | Neuroendocrine neoplasm (HP:0100634) | 1.61207530 |
| 158 | Onion bulb formation (HP:0003383) | 1.60929525 |
| 159 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.60703112 |
| 160 | Myopathic facies (HP:0002058) | 1.60271435 |
| 161 | Poor suck (HP:0002033) | 1.60157878 |
| 162 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.59720545 |
| 163 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.59720545 |
| 164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.59720545 |
| 165 | Complete atrioventricular canal defect (HP:0001674) | 1.58859557 |
| 166 | Atrioventricular canal defect (HP:0006695) | 1.58604514 |
| 167 | Dysmetric saccades (HP:0000641) | 1.58235384 |
| 168 | Hypoplasia of the odontoid process (HP:0003311) | 1.57979158 |
| 169 | Nephrogenic diabetes insipidus (HP:0009806) | 1.56614005 |
| 170 | Exotropia (HP:0000577) | 1.55578768 |
| 171 | Impaired vibratory sensation (HP:0002495) | 1.55489651 |
| 172 | Action tremor (HP:0002345) | 1.55459283 |
| 173 | Fetal akinesia sequence (HP:0001989) | 1.55010953 |
| 174 | Pointed chin (HP:0000307) | 1.54661989 |
| 175 | Abnormal hair whorl (HP:0010721) | 1.54312646 |
| 176 | Cerebral aneurysm (HP:0004944) | 1.53653028 |
| 177 | Specific learning disability (HP:0001328) | 1.53334581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.10538678 |
| 2 | EPHA4 | 3.55823448 |
| 3 | MAP3K4 | 3.01777503 |
| 4 | MAP2K7 | 2.70047025 |
| 5 | MARK1 | 2.65714108 |
| 6 | MINK1 | 2.63411776 |
| 7 | CASK | 2.49014329 |
| 8 | ICK | 2.42611997 |
| 9 | AKT3 | 2.39666151 |
| 10 | MAP3K9 | 2.31042645 |
| 11 | TAOK1 | 2.25245636 |
| 12 | CDK19 | 2.18675239 |
| 13 | MAP2K4 | 2.12621299 |
| 14 | MAP3K12 | 2.12046164 |
| 15 | ERN1 | 2.00060129 |
| 16 | GRK5 | 1.97879383 |
| 17 | DAPK1 | 1.91982298 |
| 18 | PRPF4B | 1.91497913 |
| 19 | MAP3K11 | 1.89349170 |
| 20 | MARK2 | 1.89223132 |
| 21 | EPHB1 | 1.88674456 |
| 22 | CAMKK2 | 1.87316649 |
| 23 | MAP3K6 | 1.83593738 |
| 24 | DAPK2 | 1.73508955 |
| 25 | PRKD3 | 1.72600256 |
| 26 | INSRR | 1.68013195 |
| 27 | SIK1 | 1.67759396 |
| 28 | TNIK | 1.66095171 |
| 29 | CAMKK1 | 1.56404318 |
| 30 | ARAF | 1.56308826 |
| 31 | PLK2 | 1.56203873 |
| 32 | MAPK13 | 1.55428151 |
| 33 | TNK2 | 1.54429404 |
| 34 | MAP2K3 | 1.50014225 |
| 35 | PRKD2 | 1.47386019 |
| 36 | NTRK2 | 1.47109771 |
| 37 | TSSK6 | 1.47040392 |
| 38 | PKN2 | 1.46201103 |
| 39 | RIPK1 | 1.45508734 |
| 40 | LATS2 | 1.45505144 |
| 41 | NEK1 | 1.39619892 |
| 42 | RIPK4 | 1.38429870 |
| 43 | TTN | 1.33944914 |
| 44 | CDK8 | 1.33404143 |
| 45 | MOS | 1.29109848 |
| 46 | DYRK1B | 1.28529321 |
| 47 | KSR1 | 1.25307101 |
| 48 | TESK1 | 1.21217008 |
| 49 | BRAF | 1.19616017 |
| 50 | PAK6 | 1.16693484 |
| 51 | FGFR4 | 1.16199427 |
| 52 | MAPK12 | 1.15637149 |
| 53 | SIK2 | 1.15249825 |
| 54 | WNK3 | 1.14830340 |
| 55 | TYK2 | 1.12167180 |
| 56 | DDR2 | 1.10319982 |
| 57 | ERBB3 | 1.07515088 |
| 58 | SGK2 | 1.07327289 |
| 59 | BLK | 1.07266686 |
| 60 | CDK5 | 1.06285898 |
| 61 | PRKCG | 1.05610162 |
| 62 | SCYL2 | 1.03457883 |
| 63 | NTRK1 | 1.00649208 |
| 64 | FES | 0.99670019 |
| 65 | GRK7 | 0.99313603 |
| 66 | MAP4K1 | 0.95874645 |
| 67 | EEF2K | 0.95540410 |
| 68 | CDK18 | 0.94930726 |
| 69 | UHMK1 | 0.90986181 |
| 70 | CDK15 | 0.90312116 |
| 71 | SMG1 | 0.85751398 |
| 72 | MAP3K1 | 0.85122642 |
| 73 | CDK14 | 0.84499173 |
| 74 | SGK494 | 0.83651961 |
| 75 | SGK223 | 0.83651961 |
| 76 | CDK11A | 0.80917248 |
| 77 | PHKG2 | 0.79186929 |
| 78 | PHKG1 | 0.79186929 |
| 79 | FER | 0.77511049 |
| 80 | PLK3 | 0.74588895 |
| 81 | EPHA3 | 0.74540660 |
| 82 | PTK2B | 0.74264732 |
| 83 | PDGFRA | 0.72288655 |
| 84 | KSR2 | 0.71619278 |
| 85 | ADRBK1 | 0.71180315 |
| 86 | SGK3 | 0.70650620 |
| 87 | GRK6 | 0.70346531 |
| 88 | ZAP70 | 0.70261581 |
| 89 | TGFBR2 | 0.69500186 |
| 90 | TYRO3 | 0.69328814 |
| 91 | PRKCH | 0.69120727 |
| 92 | CAMK2A | 0.68504063 |
| 93 | PASK | 0.68321267 |
| 94 | PDPK1 | 0.68315183 |
| 95 | CAMK1G | 0.67769775 |
| 96 | HCK | 0.67160742 |
| 97 | PAK3 | 0.66923700 |
| 98 | CAMK2B | 0.66065964 |
| 99 | CSK | 0.65921521 |
| 100 | RPS6KA2 | 0.63078757 |
| 101 | STK11 | 0.62304707 |
| 102 | JAK2 | 0.62078586 |
| 103 | PTK6 | 0.61800912 |
| 104 | NME1 | 0.61310159 |
| 105 | MAP3K3 | 0.61241842 |
| 106 | RET | 0.60737902 |
| 107 | CDK12 | 0.60066943 |
| 108 | PDK1 | 0.60016728 |
| 109 | TAOK2 | 0.58160371 |
| 110 | TESK2 | 0.55660257 |
| 111 | PIM2 | 0.55575623 |
| 112 | CAMK1 | 0.55280223 |
| 113 | FYN | 0.54373780 |
| 114 | CAMK4 | 0.52315601 |
| 115 | BRSK1 | 0.51375222 |
| 116 | STK38 | 0.51099254 |
| 117 | JAK1 | 0.50470606 |
| 118 | MTOR | 0.50374081 |
| 119 | PDK3 | 0.50088047 |
| 120 | PDK4 | 0.50088047 |
| 121 | PRKCE | 0.50040109 |
| 122 | RPS6KC1 | 0.49815633 |
| 123 | RPS6KL1 | 0.49815633 |
| 124 | ZAK | 0.49426085 |
| 125 | CCNB1 | 0.48728460 |
| 126 | EPHB2 | 0.48378007 |
| 127 | IRAK4 | 0.47912668 |
| 128 | PRKD1 | 0.47610528 |
| 129 | DYRK2 | 0.46956164 |
| 130 | PRKAA1 | 0.46530741 |
| 131 | MAP2K1 | 0.46298078 |
| 132 | CSF1R | 0.44982852 |
| 133 | PRKCZ | 0.44764987 |
| 134 | PTK2 | 0.43677816 |
| 135 | RPS6KB1 | 0.38901259 |
| 136 | RAF1 | 0.37850224 |
| 137 | CSNK1G2 | 0.36406254 |
| 138 | SGK1 | 0.33420979 |
| 139 | RPS6KA3 | 0.33281395 |
| 140 | DYRK1A | 0.31246791 |
| 141 | SIK3 | 0.27120840 |
| 142 | PNCK | 0.27053101 |
| 143 | MATK | 0.26817760 |
| 144 | CSNK1E | 0.26589425 |
| 145 | MAP3K7 | 0.25799279 |
| 146 | TRIB3 | 0.25696410 |
| 147 | DAPK3 | 0.25453103 |
| 148 | ALK | 0.25416551 |
| 149 | CAMK1D | 0.25031066 |
| 150 | CDC42BPA | 0.24928788 |
| 151 | MAPK7 | 0.24075032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73861732 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.61720329 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52012284 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.48485424 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43682038 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40092273 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33716763 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28725848 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.14998211 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.13921471 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07794610 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.06656063 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01972837 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92905780 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.87435188 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77847069 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.69859750 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62389932 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62281684 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60244721 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59626617 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57694698 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.56522247 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55459714 |
| 25 | Gap junction_Homo sapiens_hsa04540 | 1.55103978 |
| 26 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.54550362 |
| 27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.51023761 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50252808 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48194443 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.46087808 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.45895725 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44578015 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44195016 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40471247 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38282326 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37303088 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36531152 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34618510 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30824701 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26958390 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24670675 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21470407 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.17727671 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16426843 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16175893 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.12278319 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11684352 |
| 48 | Endocytosis_Homo sapiens_hsa04144 | 1.06022149 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.04296789 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.04041824 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03601380 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.02437922 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.01606337 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01121362 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.98405015 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98361006 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 0.97939348 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97377641 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96828637 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96325692 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94694158 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94555560 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94127924 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.91851368 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.91093839 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87538279 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87458694 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.86570254 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85219170 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84760058 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84551334 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83237660 |
| 73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.82454630 |
| 74 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81921425 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78706479 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77995659 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77742438 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76384937 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73767093 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72706389 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72092879 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71561840 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.71195013 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70490098 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.69770516 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69650723 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69482828 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66852207 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66020104 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65840149 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64003202 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63834586 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63485902 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63279560 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62783594 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62764169 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.61991255 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60679687 |
| 99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60560128 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58543086 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58233113 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.57575684 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57349800 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57280078 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55452717 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.55318781 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.55073939 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54887912 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.54711102 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54613455 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.54184746 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.53490793 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53270305 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52874477 |
| 115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52721094 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52711799 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52533578 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50391743 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50067017 |
| 120 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49704499 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46864421 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46859993 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45578057 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45074794 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45049180 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43542181 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42432873 |
| 128 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40341758 |
| 129 | Phototransduction_Homo sapiens_hsa04744 | 0.39211646 |
| 130 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37420724 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.37284354 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34714455 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34680245 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.34558181 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34452858 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33607406 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32274900 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31770471 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30668795 |

